| Bioactivity | Gp100:209-217 is a gp 100-derived human CTL epitope presented by HLA-A2. Gp100:209-217 is a polypeptide containing eight amino acids. Gp100:209-217 is a potent TGF-β inhibitor and blocks TGF-β signaling pathway[1]. |
| Name | Gp100:209-217 |
| CAS | 319927-23-6 |
| Shortening | ITQVPFSV |
| Formula | C42H67N9O12 |
| Molar Mass | 890.03 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
Gp100:209-217
CAS: 319927-23-6 F: C42H67N9O12 W: 890.03
Gp100:209-217 is a gp 100-derived human CTL epitope presented by HLA-A2. Gp100:209-217 is a polypeptide containing eight
Data collection：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.